Correction to: Comparative Effectiveness, Time to Discontinuation, and Patient-Reported Outcomes with Baricitinib in Rheumatoid Arthritis: 2-Year Data from the Multinational, Prospective Observational RA-BE-REAL Study in European Patients.
- DOI
- 10.1007/s40744-025-00799-x
- Published
- 2026 Feb
- Container
- Rheumatology and therapy
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s40744-025-00799-x,
title = {Correction to: Comparative Effectiveness, Time to Discontinuation, and Patient-Reported Outcomes with Baricitinib in Rheumatoid Arthritis: 2-Year Data from the Multinational, Prospective Observational RA-BE-REAL Study in European Patients.},
author = {Alten R and Burmester GR and Matucci-Cerinic M and Salmon JH and Östör A and Ng KJ and Gerwien J and Zaremba-Pechmann L and Brnabic AJM and Fautrel B},
year = {2026},
journal = {Rheumatology and therapy},
doi = {10.1007/s40744-025-00799-x},
url = {https://doi.org/10.1007/s40744-025-00799-x}
}RIS
TY - JOUR TI - Correction to: Comparative Effectiveness, Time to Discontinuation, and Patient-Reported Outcomes with Baricitinib in Rheumatoid Arthritis: 2-Year Data from the Multinational, Prospective Observational RA-BE-REAL Study in European Patients. AU - Alten R AU - Burmester GR AU - Matucci-Cerinic M AU - Salmon JH AU - Östör A AU - Ng KJ AU - Gerwien J AU - Zaremba-Pechmann L AU - Brnabic AJM AU - Fautrel B PY - 2026 JO - Rheumatology and therapy DO - 10.1007/s40744-025-00799-x UR - https://doi.org/10.1007/s40744-025-00799-x ER -
APA
R, A., GR, B., M, M., JH, S., A, Ö., KJ, N., J, G., L, Z., AJM, B., & B, F. (2026). Correction to: Comparative Effectiveness, Time to Discontinuation, and Patient-Reported Outcomes with Baricitinib in Rheumatoid Arthritis: 2-Year Data from the Multinational, Prospective Observational RA-BE-REAL Study in European Patients.. Rheumatology and therapy. https://doi.org/10.1007/s40744-025-00799-x
Source records
- pubmed · retrieved 2026-09-26T06:07:53.388Z